50 related articles for article (PubMed ID: 2879249)
1. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma.
Gerhard DS; Dracopoli NC; Bale SJ; Houghton AN; Watkins P; Payne CE; Greene MH; Housman DE
Nature; 1987 Jan 1-7; 325(6099):73-5. PubMed ID: 2879249
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.
Zborovskaya I; Gasparian A; Kitaeva M; Polotzky B; Tupitzin N; Machaladze Z; Gerasimov S; Shtutman M; Jakubovskaya M; Davidov M; Tatosyan A
Clin Exp Metastasis; 1996 Nov; 14(6):490-500. PubMed ID: 8970579
[TBL] [Abstract][Full Text] [Related]
3. Activated ras. Yet another player in melanoma?
Herlyn M; Satyamoorthy K
Am J Pathol; 1996 Sep; 149(3):739-44. PubMed ID: 8780377
[No Abstract] [Full Text] [Related]
4. Elevated frequency of an ETS-1 restriction fragment polymorphism in chronic B-cell leukaemia.
Crossen PE; Morrison MJ
Hum Genet; 1993 May; 91(4):380-2. PubMed ID: 8099060
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Ha-ras 1 allele frequencies in hereditary non-polyposis colorectal cancer.
Jeevaratnam P; Browett PJ; Van de Water NS; Jass JR
Gut; 1995 Mar; 36(3):382-4. PubMed ID: 7698697
[TBL] [Abstract][Full Text] [Related]
6. Ha-ras rare alleles in breast cancer susceptibility.
Conway K; Edmiston S; Fried DB; Hulka BS; Garrett PA; Liu ET
Breast Cancer Res Treat; 1995 Jul; 35(1):97-104. PubMed ID: 7612910
[TBL] [Abstract][Full Text] [Related]
7. Human hypervariable sequences in risk assessment: rare Ha-ras alleles in cancer patients.
Krontiris TG; DiMartino NA; Mitcheson HD; Lonergan JA; Begg C; Parkinson DR
Environ Health Perspect; 1987 Dec; 76():147-53. PubMed ID: 3329095
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and molecular epidemiology of human cancer: indicators of carcinogen exposure, DNA damage, and genetic predisposition.
Harris CC; Weston A; Willey JC; Trivers GE; Mann DL
Environ Health Perspect; 1987 Nov; 75():109-19. PubMed ID: 3319559
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of genetic disease using recombinant DNA. Supplement.
Cooper DN; Schmidtke J
Hum Genet; 1987 Sep; 77(1):66-75. PubMed ID: 3305309
[TBL] [Abstract][Full Text] [Related]
10. Statistical methodology in the analysis of relationships between DNA polymorphisms and disease: putative association of Ha-ras-I hypervariable alleles and cancer.
Peto TE; Thein SL; Wainscoat JS
Am J Hum Genet; 1988 Apr; 42(4):615-7. PubMed ID: 3279763
[No Abstract] [Full Text] [Related]
11. A genetic linkage map of 27 loci from PND to FY on the short arm of human chromosome I.
Dracopoli NC; Stanger BZ; Ito CY; Call KM; Lincoln SE; Lander ES; Housman DE
Am J Hum Genet; 1988 Oct; 43(4):462-70. PubMed ID: 2902785
[TBL] [Abstract][Full Text] [Related]
12. Amplified allele of the human N-myc oncogene in neuroblastomas.
Yamada M; Kurosawa H; Nakagawa Y; Nakagome Y; Tsuda T; Higashi K
Jpn J Cancer Res; 1988 Jun; 79(6):670-3. PubMed ID: 2900826
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of specific alleles of the c-Ha-ras gene in Japanese cancer patients.
Honda K; Ishizaki K; Ikenaga M; Toguchida J; Inamoto T; Tanaka K; Ozawa K
Hum Genet; 1988 Aug; 79(4):297-300. PubMed ID: 2900800
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Ha-RAS-1 proto-oncogene alleles in breast cancer patients and in a control population.
Saglio G; Camaschella C; Giai M; Serra A; Guerrasio A; Peirone B; Gasparini P; Mazza U; Ceppellini R; Biglia N
Breast Cancer Res Treat; 1988 May; 11(2):147-53. PubMed ID: 2900032
[TBL] [Abstract][Full Text] [Related]
15. DNA polymorphism and the study of disease associations.
Cooper DN; Clayton JF
Hum Genet; 1988 Apr; 78(4):299-312. PubMed ID: 2896152
[TBL] [Abstract][Full Text] [Related]
16. Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs.
Kawashima K; Shikama H; Imoto K; Izawa M; Naruke T; Okabayashi K; Nishimura S
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2353-6. PubMed ID: 2895475
[TBL] [Abstract][Full Text] [Related]
17. c-Ha-ras-1 alleles in bladder cancer, Wilms' tumour and malignant melanoma.
Hayward NK; Keegan R; Nancarrow DJ; Little MH; Smith PJ; Gardiner RA; Seymour GJ; Kidson C; Lavin MF
Hum Genet; 1988 Feb; 78(2):115-20. PubMed ID: 2892780
[TBL] [Abstract][Full Text] [Related]
18. Comparison between the allelic frequency distribution of the Ha-ras 1 locus in normal individuals and patients with lymphoma, breast, and ovarian cancer.
Corell B; Zoll B
Hum Genet; 1988 Jul; 79(3):255-9. PubMed ID: 2841224
[TBL] [Abstract][Full Text] [Related]
19. Allele-specific deletion in exon I of the HRAS1 gene.
Kasperczyk A; Mermer BA; Parkinson DR; Lonergan JA; Krontiris TG
Am J Hum Genet; 1989 Nov; 45(5):689-96. PubMed ID: 2573274
[TBL] [Abstract][Full Text] [Related]
20. TaqI polymorphism within the c-Ha-ras-1 VTR is associated with melanoma.
Hayward NK; Nancarrow DJ; Parsons PG; Kidson C; Ellem KA
Hum Genet; 1989 Nov; 83(4):395-6. PubMed ID: 2572539
[No Abstract] [Full Text] [Related]
[Next] [New Search]
